FDA Orange Book

Is there a generic for Xerava?

Xerava contains eravacycline. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Xerava (eravacycline). The Orange Book shows its last listed patent expires October 19, 2037 and its last listed exclusivity ends August 27, 2028.

Run it in Rivvi

Map Xerava and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Xerava products in the Orange Book

Xerava products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
powder, intravenousEQ 100MG BASE/VIALMarketed (Rx)None0None
powder, intravenousEQ 50MG BASE/VIALMarketed (Rx)None0None

NDA 211109, held by TETRAPHASE PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Xerava patents

Patents listed for Xerava
PatentExpiresCoversUse codeNDA
8796245August 7, 2029Method of useU-2380211109
8906887August 27, 2032Drug productNone211109
11578044October 19, 2037Drug substanceNone211109
10961190October 19, 2037Drug substanceNone211109

Xerava exclusivity

Exclusivity listed for Xerava
CodeMeaningExpiresNDA
NCENew chemical entityAugust 27, 2023211109
GAINGenerating Antibiotic Incentives NowAugust 27, 2028211109

Xerava NDC codes

Questions

Is there a generic for Xerava?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Xerava (eravacycline). The Orange Book shows its last listed patent expires October 19, 2037 and its last listed exclusivity ends August 27, 2028.

What is the generic name for Xerava?

The active ingredient in Xerava is eravacycline, per the FDA Orange Book.

When does the Xerava patent expire?

The last patent listed for Xerava in the Orange Book expires October 19, 2037. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Xerava and Eravacycline

Try it on your own data today.

Free to start. Most teams are using it the same day.